These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 6742803)

  • 61. Cholera: an overview with reference to the Yemen epidemic.
    Rabaan AA
    Front Med; 2019 Apr; 13(2):213-228. PubMed ID: 29934743
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Pathways of enzymatic inactivation of levomycetin in El Tor vibrios with plasmid and chromosome resistance to the antibiotic].
    Korobeĭnik NV; Mishan'kin BN; Sokolova MT
    Antibiotiki; 1979 Jul; 24(7):502-7. PubMed ID: 464559
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Antibiotic sensitivity of strains of nonagglutinating vibrios and El Tor vibrios].
    Ziiaev ShI; Dzhalilov KD; Satybaldieva NSh
    Antibiotiki; 1979 Feb; 24(2):105. PubMed ID: 155421
    [No Abstract]   [Full Text] [Related]  

  • 64. [Antibiotic resistance of strains of Vibrio cholerae eltor isolated in Douala (Cameroon)].
    Garrigue GP; Ndayo M; Sicard JM; Fonkoua MC; Lemao G; Durand JP; Dodin A
    Bull Soc Pathol Exot Filiales; 1986; 79(3):305-12. PubMed ID: 3769118
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Laboratory investigation and infection control of cholera in Kingston, Ont.
    Lewis RG; Smith ID; O'Shaughnessy MV; Tennant RD; Lior H; Krol PM; Toma S; Metcalf E; Kelly RA; Johnson SE; Sprenger RA; Davies JD
    Can Med Assoc J; 1976 Sep; 115(5):397-8. PubMed ID: 953913
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antibiotic resistance mechanisms of Vibrio cholerae.
    Kitaoka M; Miyata ST; Unterweger D; Pukatzki S
    J Med Microbiol; 2011 Apr; 60(Pt 4):397-407. PubMed ID: 21252269
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Emergence of multiple drug-resistant Vibrio cholerae O1 in San Pedro Sula, Honduras.
    Dubon JM; Palmer CJ; Ager AL; Shor-Posner G; Baum MK
    Lancet; 1997 Mar; 349(9056):924. PubMed ID: 9093259
    [No Abstract]   [Full Text] [Related]  

  • 68. [Development of multiple antibiotic resistance in vivo in cholera vibrions].
    Podosinnikova LS; Domoradskii IV
    Antibiotiki; 1973 May; 18(5):449-53. PubMed ID: 4781216
    [No Abstract]   [Full Text] [Related]  

  • 69. Antibiotic resistance of vibrio cholerae: special considerations of R-plasmids.
    Kuwahara S
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1978 Sep; 11(3):99-103. PubMed ID: 581573
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Emergence of multiple drug resistance in Vibrio cholerae O1 El Tor from Ecuador.
    Threlfall EJ; Said B; Rowe B
    Lancet; 1993 Nov; 342(8880):1173. PubMed ID: 7901494
    [No Abstract]   [Full Text] [Related]  

  • 71. [Current problems of El Tor cholera].
    Solt K; Budai J; Vass A; Erdös L
    Orv Hetil; 1974 Mar; 115(9):488-91. PubMed ID: 4815452
    [No Abstract]   [Full Text] [Related]  

  • 72. Fluoroquinolone resistance in Vibrio cholerae O1: emergence of El Tor Inaba.
    Das S; Goyal R; Ramachandran VJ; Gupta S
    Ann Trop Paediatr; 2005 Sep; 25(3):211-2. PubMed ID: 16156987
    [No Abstract]   [Full Text] [Related]  

  • 73. [Antibiotic sensitivity of El Tor Vibrio cholerae after exposure to various pesticides and mineral fertilizers].
    Ziiaev ShI; Vallamatov ST; Zaĭtseva TS; Ismailov II
    Antibiot Khimioter; 1991 Aug; 36(8):37-9. PubMed ID: 1661574
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Vibrio cholerae El Tor acquires plasmid-encoded resistance to gentamicin.
    Threlfall EJ; Rowe B
    Lancet; 1982 Jan; 1(8262):42. PubMed ID: 6119431
    [No Abstract]   [Full Text] [Related]  

  • 75. Unusual multiresistant Vibrio cholerae O1 El Tor in Argentina.
    Rossi A; Galas M; Binztein N; Rivas M; Caffer MI; Corso A; Radice M; Gutkind G
    Lancet; 1993 Nov; 342(8880):1172-3. PubMed ID: 7901493
    [No Abstract]   [Full Text] [Related]  

  • 76. [The characteristics of the antibacterial therapy for cholera in Dagestan].
    Karbyshev GL; Lomov IuM; Terent'ev AN; Fatsaĭlova OP; Golubev BP; Bespalov AI; Mazrukho AB; Ivanova NG
    Zh Mikrobiol Epidemiol Immunobiol; 1995; Suppl 2():71-4. PubMed ID: 7771151
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Emergence and rapid spread of tetracycline-resistant Vibrio cholerae strains, Madagascar.
    Dromigny JA; Rakoto-Alson O; Rajaonatahina D; Migliani R; Ranjalahy J; Mauclére P
    Emerg Infect Dis; 2002 Mar; 8(3):336-8. PubMed ID: 11927038
    [No Abstract]   [Full Text] [Related]  

  • 78. The in vitro activity of Midecamycin against various Vibrio species.
    Bonang G; Surjawidjaja JE; Santoso US
    Jpn J Exp Med; 1975 Feb; 45(1):43-5. PubMed ID: 1228226
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of in vitro activity of mecillinam with other antimicrobial chemotherapeutic agents against Salmonella Shigella and El Tor Vibrio cholerae.
    Mhalu FS; Swai V; Runyoro D; Shao JF
    East Afr Med J; 1982 Oct; 59(10):676-81. PubMed ID: 6309499
    [No Abstract]   [Full Text] [Related]  

  • 80. Identification of Small Molecule Inhibitors of the Pathogen Box against Vibrio cholerae.
    Kim H; Burkinshaw BJ; Lam LG; Manera K; Dong TG
    Microbiol Spectr; 2021 Dec; 9(3):e0073921. PubMed ID: 34937180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.